Description  Claims  Drawing  Cited references 

WO2008106702A   [0010] 

Peritoneal solute transport predicts survival on CAPD independently of residual renal function   [0072] 
Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF   [0072] 
Glucose degradation products increase apoptosis of human mesothelial cells   [0072] 
Role of glycogen synthase kinase-3beta in cardioprotection   [0072] 
Regulation of glycogen synthase activation in isolated hepatocytes   [0072] 
Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice   [0072] 
Upregulation by retinoic acid of transforming growth factor-beta-stimulated heat shock protein 27 induction in osteoblasts: involvement of mitogen-activated protein kinases   [0072] 
GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy   [0072] 
Repression of the heat shock factor 1 transcriptional activation domain is modulated by constitutive phosphorylation   [0072] 
Glycogen synthase kinase 3β and extracellular signal-regulated kinase inactivate heat shock transcription factor 1 by facilitating the disappearance of transcriptionally active granules after heat shock   [0072] 
Transcriptional activity of heat shock factor 1 at 37 degrees C is repressed through phosphorylation on two distinct serine residues by glycogen synthase kinase 3 and protein kinases Cα and Cζ   [0072] 
Quercetin protects human mesothelial cells against exposure to peritoneal dialysis fluid   [0072] 
Overexpression of HSP-72 confers cytoprotection in experimental peritoneal dialysis   [0072] 
Alanyl-Glutamine dipeptide restores the cytoprotective stress proteome of mesothelial cells exposed to peritoneal dialysis fluids   [0072] 
Glycogen synthase kinase 3beta is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells   [0072] 
GSK3 inhibitors: development and therapeutic potential   [0072] 
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics   [0072] 
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium   [0072] 
HSP72 inhibits Smad3 activation and nuclear translocation in renal epithelial-to-mesenchymal transition   [0072] 
Advanced glycation end-product-inhibited cell proliferation and protein expression of beta-catenin and cyclin D1 are dependent on glycogen synthase kinase 3beta in LLC-PK1 cells   [0072] 
GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder   [0072] 
GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke   [0072] 
Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice   [0072] 
Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo   [0072] 
Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase   [0072] 
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes   [0072] 
Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites   [0072] 
Intraperitoneal lithium administration for bipolar affective disorder in a patient on continuous ambulatory peritoneal dialysis   [0072] 
Lithium carbonate decreases ultrafiltration rates in an experimental model of PD   [0072] 
Enhancement of neuroprotection and heat shock protein induction by combined prostaglandin A1 and lithium in rodent models of focal ischemia   [0072] 
Greater stress protein expression enhanced by combined prostaglandin A1 and lithium in a rat model of focal ischemia   [0072] 
Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model   [0072] 
Lithium neuroprotection: molecular mechanisms and clinical implications   [0072] 
IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AB-1 proteins   [0072]